2022 International Congress

September 15-18, 2022. Madrid, Spain.

View by Title View Categories

Jump to: View All • a b c d e f g h i j k l m n o p q r s t u [v] w x y z

Validating a virtual Timed Up and Go (vTUG) test in Parkinson’s Disease.

C. Matthews, R. Roberts, E. Davies, B. Falkenburger, M. Grobe-Einsler (Wrexham, United Kingdom)
VALIDATING ACCELEROMETRY AS A MEASURE OF ENERGY EXPENDITURE AND PHYSICAL ACTIVITY IN ADULTS WITH HUNTINGTON’S DISEASE

L. Simón, E. Cubo, J. Rivadeneyra, C. Collazo, M. Soto, J. Raya, D. Castillo, S. Calvo, A. Fernández (Burgos, Spain)
Validation of a patient-reported functional mobility composite score (FMCS) in people with typical Parkinson’s disease

AMH. Hanff, A. Rauschenberger, C. Mccrum, G. Aguayo, M. Zeegers, A. Leist, R. Krüger (Strassen, Luxembourg)
Validation of a wireless Home-Based Sleep Laboratory for assessment of sleep-related disorders in Parkinson’s disease

S. Oz, A. Dagay, S. Katzav, D. Wasserman, E. Harduff, Y. Hanein, A. Mirelman (Tel Aviv, Israel)
Validation of Direct/Indirect targets with intra-operative clinical assessment in the Indian population & comparison with image guided and MER based targeting for Subthalamic Nucleus(STN) based Deep Brain Stimulation(DBS) in Parkinson’s disease(PD)

A. Uppar, D. Srinivas, R. Yadav, P. Pal, V. Holla (BANGALORE, India)
Validation of fully automated tremor analysis on common videos based on Computer Vision.

R. Wolke, J. Welzel, D. Brinker, G. Deuschl, J. Becktepe (Kiel, Germany)
Validation of the English version of the Parkinson Anxiety Scale in the Canadian population: Interim results

J. Lam, X. Tang, D. Meng, P. Uzelman, A. Yu, S. Appel-Cresswell (Vancouver, Canada)
Validation of the PD Home Diary for Assessment of Motor Fluctuations in Advanced Parkinson’s Disease

M. Löhle, A. Bremer, F. Gandor, J. Timpka, P. Odin, G. Ebersbach, A. Storch (Rostock, Germany)
Validity and reliability of the Thai version of the Freezing of Gait Questionnaire (FOG-Q) in individuals with Parkinson’s disease (PD)

A. Taweekitikul, P. Tanvijit (Bangkok, Thailand)
Value of Archimedes spiral in tremor.

A. Fernández Revuelta, P. Mayo Rodríguez, V. Gómez Mayordomo, E. Sanesteban Beceiro, R. García-Ramos, E. López Valdés, F. Alonso Frech (Madrid, Spain)
Variability in Age of Onset, Age of Diagnosis and Age of Death for Progressive Supranuclear Palsy Patients Among Three Racial Groups in Hawai`i

A. Kannan, F. Gao, G. Fujikami, M. Bruno (Honolulu, USA)
Variability of Plasma Levodopa Conveniently Reduced by More Frequent Administration of Smaller Doses of Carbidopa/Levodopa Using a Novel Functionally Scored Formulation

A. Al-Sabbagh, S. Testino, M. Koga, T. Chase, K. Smith (Alpharetta, USA)
Vascular Causes of Atypical Parkinsonism Versus Vascular Contribution Towards Atypical Parkinsonism

M K. Acharya (KHARAGPUR, India)
Verifying imaging accuracy for targeting and lead positioning in DBS: a phantom study.

A. Rohaan, Y. Willems, N. Vander Gaag (Leiden, Netherlands)
Very long time persistent hyperCKemia as the first manifestation of McLeod syndrome

E. Muñoz, V. Torres, C. Painous, P. Santacruz, A. Sánchez, C. Sanz, JM. Grau-Junyent (Barcelona, Spain)
Video-guided Optimization of Stimulation Settings in Patients with Parkinson’s Disease and Deep Brain Stimulation

C. Schedlich-Teufer, H. Jergas, J. Steffen, J. Strelow, H. Dafsari, V. Visser-Vandewalle, M. Barbe, J. Wirths (Cologne, Germany)
Video-oculographic biomarkers for evaluating vertical ocular dysfunction in progressive supranuclear palsy

A. Quattrone, M. Crasà, M. Morelli, B. Vescio, A. Augimeri, V. Gramigna, A. Quattrone (Catanzaro, Italy)
Virtual Visit Experience of the Portland Oregon Pacific UDALL Center During COVID-19

B. Lobb, K. Chung, A. Hiller, J. Quinn (Portland, USA)
Visual Hallucinations and Parkinson’s Disease Neuropathology among Decedents with and without Parkinson’s Disease or Lewy Body Dementia During Life

H. Petrovitch, R. Abbott, M. Barrett, K. Masaki, C. Tanner, J. Uyehara-Lock, W. Ross (Honolulu, USA)
Visual system abnormalities and visual hallucinations in Parkinson’s disease

M. Diez-Cirarda, A. Cabrera, A. Murueta-Goyena, A. Strafella, R. Del Pino, MA. Acera, O. Lucas-Jiménez, N. Ibarretxe-Bilbao, B. Tijero, JC. Gomez-Esteban, I. Gabilondo (Barakaldo, Spain)
Visualising cholinergic nerves in dementia with Lewy bodies using PET and FEOBV

N. Okkels, J. Horsager, A. Hansen, M. Damholdt, P. Kjeldsen, K. Vestergaard, K. Andersen, C. Skjærbæk, T. Fedorova, J. Mortensen, G. Bekan, H. Gottrup, P. Borghammer (Aarhus N, Denmark)
Visuospatial deficits characterize Pisa syndrome and not Camptocormia in Parkinson’s disease

CA. Artusi, E. Montanaro, R. Erro, N. Margraf, C. Geroin, F. Spagnolo, A. Pilotto, L. Magistrelli, A. Marchet, M. Zibetti, C. Comi, A. Padovani, M. Tinazzi, L. Lopiano (Torino, Italy)
Vodobatinib, a potent, orally bioavailable brain-penetrating inhibitor of c-Abl as a potential neuroprotective agent for the treatment of Parkinson’s Disease

R. Walsh, S. Piccoli, O. Hurko, N. Damle, V. Ramanathan, S. Yao, D. Love, S. Mandhane, R. Talluri (Princeton, USA)
Volumetric analysis of the Corpus Callosum in Hereditary Cerebellar Ataxia

A. Adarmes Gomez, M. Reina, M. Grothe, M. Labrador-Espinosa, S. Jesus, D. Garcia, L. Muñoz-Delgado, F. Carrillo-Garcia, P. Mir (Sevilla, Spain)
Voluntary saccades slowness in parkinson disease and multiple system atrophy

JY. Yoon, CY. Lee, HJ. Kim, SH. Kim (Seoul, Republic of Korea)

Jump to: View All • a b c d e f g h i j k l m n o p q r s t u [v] w x y z